Name: 글로벌 시장 동향
SKU: MD6731
Availability: InStock

보고서 요약(국문)

시장 개요
전 세계 네뷸라이저 시장은 2022년 9억 4,440만 달러 규모에 도달했으며, 2023년부터 2030년까지 연평균 7.2%의 성장률을 보이며 2030년에는 16억 3,400만 달러에 이를 것으로 예상됩니다.
네뷸라이저는 기체에 분산된 미세한 물방울을 분무하여 기도 수분 공급 및 약물 전달에 도움을 줍니다. 제트식, 회전 디스크식, 초음파식 등 다양한 유형이 있습니다. 제트식 네뷸라이저는 고압 기체와 벤투리관을 이용하여 압력 차이를 발생시켜 저장소의 액체를 기체 쪽으로 끌어당깁니다. 초음파식 네뷸라이저는 고주파 진동을 이용하여 미세한 물방울을 생성합니다.
또한, 전 세계 네뷸라이저 시장은 호흡기 질환 유병률 증가, 기술 발전, 환자들의 네뷸라이저 사용 증가 등 다양한 요인에 힘입어 예측 기간 동안 성장할 것으로 예상됩니다.

시장 동향
호흡기 질환 유병률 증가
호흡기 질환 유병률 증가는 예측 기간 동안 시장 성장을 견인하는 주요 요인 중 하나입니다. 호흡기 질환이 증가함에 따라 네뷸라이저 기기 사용이 급증하고 있으며, 이는 시장 성장을 더욱 촉진할 것입니다.
예를 들어, 미국 질병통제예방센터(CDC)에 따르면 만성 폐쇄성 폐질환(COPD)은 전 세계적으로 약 2천억 명에게 영향을 미치고 있으며, 매년 32억 명이 사망하여 세계 사망 원인 3위를 차지하고 있습니다.
천식은 가장 흔한 비전염성 질환 중 하나로 전 세계 2,620억 명에게 영향을 미칩니다. 2022년에는 약 22억 건의 새로운 폐암 발병 사례와 18억 명의 사망자가 발생할 것으로 예상되며, 폐암은 전 세계 암 사망의 4분의 1을 차지합니다. 하부 호흡기 감염 또는 폐렴은 주요 사망 원인으로, 매년 24억 명 이상이 이 질환으로 사망하며, 주로 저소득 및 중소득 국가(LMICs)에서 발생합니다.
분무기 기술 발전
분무기 기술의 발전은 예측 기간 동안 시장 성장을 견인하는 중요한 요인입니다. 이러한 기술 발전으로 더욱 효율적이고 사용하기 쉬운 기기가 개발되었을 뿐만 아니라, 약물 투여 방식이 개선되고 휴대성이 향상되었습니다.
진동 메쉬 분무기(수동 및 능동 진동 메쉬 모두)는 10년 이상 사용되어 왔으며, 주요 기술 발전을 보여줍니다. 이러한 기기는 일반적으로 여러 개의 구멍(또는 메쉬)이 있는 진동판을 사용하여 액체를 미세한 물방울 형태로 분사합니다. 메쉬 진동은 종종 압전 소자(수동 또는 능동)에 의해 구동되며, 지속적으로 작동하거나 흡입과 동기화하여 작동할 수 있습니다.
분무액의 부작용
분무액의 부작용은 시장 성장을 저해하는 요인 중 하나입니다. 일부 부작용으로는 기침, 코막힘, 메스꺼움, 재채기, 천명 등이 있습니다. 임상 시험에서는 졸음, 코 가려움, 코피, 코 작열감, 혈청병, 복통과 같은 다른 부작용도 보고되었습니다. 따라서 위와 같은 요인으로 인해 네뷸라이저의 공급이 감소하고 이는 전체 시장에 영향을 미칠 것입니다.
세그먼트 분석
글로벌 네뷸라이저는 유형, 방식, 적용 분야, 최종 사용자 및 지역별로 세분화됩니다.
유형 부문 중 제트 네뷸라이저가 전체 네뷸라이저 시장 점유율의 약 42.5%를 차지했습니다.
제트 네뷸라이저는 약 42.5%의 시장 점유율을 차지하며, 비용 효율성과 사용 편의성으로 인해 예측 기간 동안 시장을 주도할 것으로 예상됩니다. 제트 네뷸라이저는 압축 공기 또는 산소를 좁은 구멍을 통해 분당 6~8리터의 속도로 통과시켜 저장소에서 공급 튜브로 약물 용액을 흡입하는 방식입니다. 이 튜브에는 미세한 섬유 다발이 있으며, 용액이 이 섬유 다발에 부딪히면서 미세한 물방울이 생성됩니다(벤투리 원리).
또한, 제트 분무기는 사용이 간편하고 약물 전달 효율이 높은 설계로 인해 수년간 주요 제품으로 자리 잡았습니다. 제트 분무기는 건조 분말 흡입기(DPH)나 가압식 정량 흡입기(PDM)로는 전달할 수 없는 제형을 효과적으로 전달할 수 있습니다. 뿐만 아니라, 제트 분무기 외에도 주름관형 분무기, 수집 백형 분무기, 호흡 강화형 분무기, 호흡 작동형 분무기 등 다양한 설계의 분무기가 있습니다.
지역별 시장 점유율
북미, 2022년 시장 점유율 약 38.4% 차지
북미는 분무기 분야의 지속적인 기술 혁신과 여러 기관의 투자 덕분에 예측 기간 동안 전체 시장 점유율의 약 38.4%를 차지할 것으로 예상됩니다. 이 지역 인구의 생활 방식이 빠르게 변화함에 따라, 천식 및 기타 기도 질환 환자들은 필요할 때 쉽게 휴대할 수 있는 휴대용 네뷸라이저 장치를 더욱 많이 찾고 있습니다.
예를 들어, 2020년 6월, 레노비온(Renovion)사는 비낭포성 섬유증 기관지확장증 및 낭포성 섬유증 환자의 점액을 제거하고 염증을 줄이는 실험적인 네뷸라이저 치료법인 ARINA-1(아스코르브산)의 임상 개발을 위해 81억 달러의 자금을 조달했습니다.
경쟁 환경
네뷸라이저 시장의 주요 글로벌 업체로는 Vyaire Medical, Koninklijke Philips N.V, Allied Healthcare, Drive DeVilbiss Healthcare, PARI Respiratory Equipment, Inc, Aerogen, Beurer GmBH, OMRON Healthcare Inc, Agilent Technologies, Microlife Corporation 등이 있습니다.

COVID-19 영향 분석
2021년 1월 PubMed Central에 게재된 "COVID-19 팬데믹 기간 중 분무 요법에 대한 지침"이라는 논문에서는 환자들이 SARS-CoV-2의 공기 전파 가능성을 인지하고 있었기 때문에 바이러스 전파 및 면역 억제의 잠재적 원인으로 여겨지는 흡입 약물 사용을 꺼렸다고 언급했습니다. 그러나 천식이나 만성 폐쇄성 폐질환(COPD) 환자는 모든 흡입 약물을 지시대로 계속 사용해야 합니다.
일부 연구자들은 분무 치료가 비말 및 에어로졸을 통한 감염 전파 위험을 증가시킬 수 있다고 주장하지만, 가압식 정량 흡입기(pMDI), 건조 분말 흡입기(DPI), 연질 분무 흡입기(SMI)와 같은 흡입기는 오염 위험이 낮은 것으로 나타났습니다. 결과적으로 COVID-19는 상당한 영향을 미쳤습니다.

러시아-우크라이나 분쟁 분석
러시아-우크라이나 분쟁은 해당 지역의 주요 시장 참여 업체 수가 적고 부재하기 때문에 전 세계 네뷸라이저 시장에 중간 정도의 영향을 미칠 것으로 예상됩니다. 그러나 기기 수출입은 예측 기간 동안 전 세계 네뷸라이저 시장 성장에 미미한 영향을 미칠 것으로 전망됩니다.

유형별
• 제트형
• 초음파형
• 메쉬형
모드별
• 탁상형
• 휴대용
적용 분야별
• 천식
• 낭포성 섬유증
• 만성 폐질환
최종 사용자별
• 병원 및 클리닉
• 응급 센터
• 가정 간호 환경
지역별
• 북미
o 미국
o 캐나다
o 멕시코
• 유럽
o 독일
o 영국
o 프랑스
o 스페인
o 이탈리아
o 기타 유럽
• 남미
o 브라질
o 아르헨티나
o 기타 남미
• 아시아 태평양
o 중국
o 인도
o 일본
o 호주
o 기타 아시아 태평양
• 중동 및 아프리카
주요 개발 사항
 2022년 7월, Ziccum은 분무기 분야에 대한 첨단 기술을 보유한 혁신적인 메카트로닉스 제조업체인 TEKCELEO와 새로운 분무기 개발 계약을 체결했습니다. 이 구성 요소는 냉장 보관이 필요 없는 내열성 분말 형태로 백신을 제조하는 Ziccum의 LaminarPace 시스템의 고급 건조 기능 및 규모 확장에 핵심적인 역할을 합니다.
 2021년 3월, 호흡기 건강 기술 혁신 기업인 MRON Healthcare는 미국 천식 및 알레르기 재단(AAFA)과 협력하여 처방 등급 호흡기 기술에 대한 접근성을 높였습니다. OMRON은 의료용 네뷸라이저를 기증했으며, AAFA는 이를 활용하여 취약한 천식 환자 커뮤니티를 위한 옹호 및 교육 활동을 펼칠 예정입니다.

보고서 구매 이유:

• 유형, 방식, 적용 분야, 최종 사용자 및 지역별 글로벌 네뷸라이저 시장 세분화를 시각화하고 주요 상업 자산 및 업체를 파악합니다.

• 트렌드 분석 및 공동 개발을 통해 사업 기회를 식별합니다.

• 모든 세그먼트를 포함한 글로벌 네뷸라이저 시장 수준의 다양한 데이터가 담긴 Excel 데이터 시트.

• 심층적인 질적 인터뷰와 연구를 바탕으로 한 종합적인 분석이 담긴 PDF 보고서.

• 주요 업체들의 핵심 제품을 모두 포함하는 제품 맵핑 자료를 엑셀 파일로 제공합니다.
글로벌 네뷸라이저 시장 보고서는 약 53개의 표, 54개의 그림, 그리고 195페이지 분량으로 구성됩니다.
2023년 주요 독자층
• 제조업체/구매자
• 산업 투자자/투자은행
• 시장 조사 전문가
• 신흥 기업

보고서 요약(영어 원문)

Market Overview
Global nebulizers market reached US$ 944.4 million in 2022 and is expected to reach US$ 1,634.0 million by 2030 growing with a CAGR of 7.2% during the forecast period 2023-2030.
Nebulizers work by creating a mist of droplets that are suspended in a gas which can be useful for airway hydration and medication delivery. Different types exist such as jet, spinning disc, and ultrasonic nebulizers. Jet nebulizers take high-pressure gas and use a venturi to cause a pressure differential, which draws liquid from the reservoir to the gas. While ultrasonic nebulizers use high-frequency vibrations to create a mist.
Furthermore, the global nebulizers market is driven by various factors like, increasing prevalence of respiratory diseases, technological advancements, and rapid adoption of these devices among the patient population and others helping the market to grow during the forecast period.
Market Dynamics
Rise in Prevalence of Respiratory Diseases
The rise in the prevalence of respiratory diseases is one of the key driver that helps the market to grow during the forecast period. Since the rise in respiratory diseases, the use of nebulizer devices is often used rapidly which indeed will increase the market growth.
For instance, according to the Centres for Disease Control and Prevention Chronic Obstructive Pulmonary Devices (COPD) affects an estimated 200 Billion people, with 3.2 Billion dying each year, making it the third-leading cause of mortality globally.
Asthma is one of the most common noncommunicable illnesses, impacting 262 Billion people worldwide. With almost 2.2 Billion new instances of lung cancer expected in 2022 and 1.80 Billion fatalities, lung cancer accounts for one in every four cancer deaths worldwide. Lower respiratory tract infection or pneumonia is a prominent cause of death, accounting for more than 2.4 Billion fatalities each year, primarily in low and middle-income countries (LMICs).
Technological Advancements in Nebulizers
Technological advancements in nebulizers play an important role in driving the market during the forecast period. They have resulted in the creation of more efficient and user-friendly devices, as well as improved pharmaceutical administration methods and increased portability.
Vibrating mesh nebulizers (both passive and active vibrating mesh) have been in use for over a decade and represent a major technological advancement. These devices generally use a vibrating plate with multiple apertures (or a mesh) to break the liquid into well-controlled streams of droplets. The mesh vibration is often driven by a piezoelectric element (passively or actively) and can be operated continuously or synchronized with inhalation.
Side Effects of Nebulizer Solutions
The side effects of nebulizer solutions are one of the restraints which hamper the market growth. Some of the side effects include cough, nasal congestion, nausea, sneezing, and wheezing. Other reactions have been reported in clinical trials, drowsiness, nasal itching, nose bleed, nose burning, serum sickness, and stomachache. Thus due to the above factors there will decline in the availability of nebulizers which indeed affects the overall market.
Segment Analysis
The global nebulizers is segmented based on type, modality, application, end user and region.
The Jet Nebulizers From The Type Segment Accounted for Approximately 42.5% of the Nebulizers Share
The jet nebulizers from the type segment with around 42.5% is expected to dominate during the forecast period, due to cost-effectiveness and ease of some nebulizers will drive the segment growth during the forecast period. Jet nebulisers use compressed air or oxygen passing through a narrow orifice at 6–8 L/minute to suck drug solution from a reservoir into a feed tube. There are fine ligaments in this tube, and the impact of the solution on these ligaments generates droplets (Venturi principle).
Besides, the ease of handling nebulizers and efficient design for drug delivery has made jet nebulizers the prime segment over the years. Jet nebulizers are effective in delivering formulations that cannot be delivered with dry powder inhalers and pressurized metered-dose inhalers. In addition, nebulizers are available in various designs including jet nebulizers along with corrugated tubes, collection bags, breath-enhanced, and breath-actuated jet nebulizers, and others.
Geographical Penetration
North America Accounted for Approximately 38.4% of the Market Share in 2022
North America is estimated to hold about 38.4% of the total market share throughout the forecast period, due to continuous technological innovations in the field of nebulizers, and funding from various organizations. As the population in the region follows a fast-moving lifestyle, patients are looking for more portable nebulizer devices that can be transferred easily in a time of need for patients with asthma and other airway diseases.
For instance, in June 2020, the company Renovion raised USD 8.1 Billion in funding for the clinical development of ARINA-1 (ascorbic acid), which is an experimental nebulizer therapy to clear mucus and reduce inflammation in people with non-cystic fibrosis bronchiectasis and cystic fibrosis.
Competitive Landscape
The major global players in the nebulizers market include Vyaire Medical, Koninklijke Philips N.V, Allied Healthcare, Drive DeVilbiss Healthcare, PARI Respiratory Equipment, Inc, Aerogen, Beurer GmBH, OMRON Healthcare Inc, Agilent Technologies, Microlife Corporation and among others.
COVID-19 Impact Analysis
The article Guidance on nebulization during the current COVID-19 pandemic published in PubMed Central in January 2021 stated that patients were hesitant to use inhalation drugs that were thought to be possible sources of viral transmission and immunosuppression because they were aware of the possibility of SARS-CoV-2 airborne transmission. Patients with asthma or chronic obstructive pulmonary disease (COPD) should, however, continue to use all inhalation medications as indicated.
While some researchers believe that nebulizer treatments may increase the risk of infection transmission via droplet nuclei and aerosols, it appears that inhalers, such as pressurised metered-dose inhalers (pMDI), dry powder inhalers (DPI), or soft mist inhalers (SMIs), have a low risk of contamination. As a result, COVID-19 had a significant influence.
Russia Ukraine Conflict Analysis
The Russia-Ukraine conflict is estimated to have a moderate impact on the global nebulizers market, owing to the low prevalence and absence of key market players in this region. However, the impact of the import and export of devices is expected to have little influence over the global nebulizers market growth over the forecast period.
By Type
• Jet
• Ultrasonic
• Mesh
By Modality
• Tabletop
• Portable
By Application
• Asthma
• Cystic Fibrosis
• Chronic Pulmonary
By End User
• Hospitals and Clinics
• Emergency Centers
• HomeCare Settings
By Region
• North America
o U.S.
o Canada
o Mexico
• Europe
o Germany
o U.K.
o France
o Spain
o Italy
o Rest of Europe
• South America
o Brazil
o Argentina
o Rest of South America
• Asia-Pacific
o China
o India
o Japan
o Australia
o Rest of Asia-Pacific
• Middle East and Africa
Key Developments
 In July 2022, Ziccum signed an agreement with TEKCELEO, an innovative mechatronic manufacturer with advanced knowledge of nebulizers, for the development of its new nebulizer. The component is central to the advanced drying capabilities and scaleup of Ziccum’s LaminarPace system, which formulates vaccines as thermostable powders that require no cold chain transport.
 In March 2021, MRON Healthcare, a leading respiratory health technology innovator, partnered with the Asthma and Allergy Foundation of America to increase access to prescription-grade respiratory technologies. OMRON donates medical-grade nebulizers, which AAFA will use for advocacy and education initiatives, benefiting vulnerable asthma communities.
Why Purchase the Report?
• To visualize the global nebulizers market segmentation based on type, modality, application, end user and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of global nebulizers market level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global nebulizers market report would provide approximately 53 tables, 54 figures and 195 pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Type
3.2. Snippet by Modality
3.3. Snippet by Application
3.4. Snippet by End User
3.5. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rise in Prevalence of Respiratory Diseases
4.1.1.2. Technological Advancements in Nebulizers
4.1.2. Restraints
4.1.2.1. Side Effects of Nebulizer Solutions
4.1.3. Opportunity
4.1.3.1. Rising Agreements with Key Players
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID-19
6.1.2. Scenario During COVID-19
6.1.3. Scenario Post Covid-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. By Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
7.1.2. Market Attractiveness Index, By Type
7.2. Jet Nebulizers *
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Mesh Nebulizers
7.4. Ultrasonic Nebulizers
8. By Modality
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
8.1.2. Market Attractiveness Index, By Modality
8.2. Tabletop *
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Portable
9. By Application
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.2. Market Attractiveness Index, By Application
9.2. Asthma*

9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Cystic Fibrosis
9.4. Chronic Obstructive Pulmonary Disease
10. By End User
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.1.2. Market Attractiveness Index, By End User
10.2. Hospitals and Clinics *
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Emergency Centers
10.4. Homecare Services
10.5. Others
11. By Region
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.2.7.1. U.S.
11.2.7.2. Canada
11.2.7.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.3.7.1. Germany
11.3.7.2. U.K.
11.3.7.3. France
11.3.7.4. Spain
11.3.7.5. Italy
11.3.7.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.4.7.1. Brazil
11.4.7.2. Argentina
11.4.7.3. Rest of South America
11.5. Asia-Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.5.7.1. China
11.5.7.2. India
11.5.7.3. Japan
11.5.7.4. Australia
11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Modality
11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis
13. Company Profiles
13.1. Vyaire Medical *
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Financial Overview
13.1.4. Key Developments
13.2. Koninklijke Philips N.V
13.3. Allied Healthcare
13.4. Drive DeVilbiss Healthcare
13.5. PARI Respiratory Equipment, Inc
13.6. Aerogen
13.7. Beurer GmBH
13.8. OMRON Healthcare Inc
13.9. Agilent Technologies
13.10. Microlife Corporation
LIST NOT EXHAUSTIVE
14. Appendix
14.1. About Us and Services
14.2. Contact Us

언급된 주요 기업들

Vyaire Medical, 4.	Key Developments, Koninklijke Philips N.V, Allied Healthcare, Drive DeVilbiss Healthcare, PARI Respiratory Equipment, Inc, Aerogen, Beurer GmBH, OMRON Healthcare Inc, Agilent Technologies, Microlife Corporation

표 목록 (Tables)

List of Tables

Table 1 Global Nebulizer Market Value, By Type, 2024, 2028 & 2033 (US$ Million)

Table 2 Global Nebulizer Market Value, By Portability, 2024, 2028 & 2033 (US$ Million)

Table 3 Global Nebulizer Market Value, By Application, 2024, 2028 & 2033 (US$ Million)

Table 4 Global Nebulizer Market Value, By End-User, 2024, 2028 & 2033 (US$ Million)

Table 5 Global Nebulizer Market Value, By Region, 2024, 2028 & 2033 (US$ Million)

Table 6 Global Nebulizer Market Value, By Type, 2024, 2028 & 2033 (US$ Million)

Table 7 Global Nebulizer Market Value, By Type, 2018-2033 (US$ Million)

Table 8 Global Nebulizer Market Value, By Portability, 2024, 2028 & 2033 (US$ Million)

Table 9 Global Nebulizer Market Value, By Portability, 2018-2033 (US$ Million)

Table 10 Global Nebulizer Market Value, By Application, 2024, 2028 & 2033 (US$ Million)

Table 11 Global Nebulizer Market Value, By Application, 2018-2033 (US$ Million)

Table 12 Global Nebulizer Market Value, By End-User, 2024, 2028 & 2033 (US$ Million)

Table 13 Global Nebulizer Market Value, By End-User, 2018-2033 (US$ Million)

Table 14 Global Nebulizer Market Value, By Region, 2024, 2028 & 2033 (US$ Million)

Table 15 Global Nebulizer Market Value, By Region, 2018-2033 (US$ Million)

Table 16 North America Nebulizer Market Value, By Type, 2018-2033 (US$ Million)

Table 17 North America Nebulizer Market Value, By Portability, 2018-2033 (US$ Million)

Table 18 North America Nebulizer Market Value, By Application, 2018-2033 (US$ Million)

Table 19 North America Nebulizer Market Value, By End-User, 2018-2033 (US$ Million)

Table 20 North America Nebulizer Market Value, By Country, 2018-2033 (US$ Million)

Table 21 Asia-Pacific Nebulizer Market Value, By Type, 2018-2033 (US$ Million)

Table 22 Asia-Pacific Nebulizer Market Value, By Portability, 2018-2033 (US$ Million)

Table 23 Asia-Pacific Nebulizer Market Value, By Application, 2018-2033 (US$ Million)

Table 24 Asia-Pacific Nebulizer Market Value, By End-User, 2018-2033 (US$ Million)

Table 25 Asia-Pacific Nebulizer Market Value, By Country, 2018-2033 (US$ Million)

Table 26 Europe Nebulizer Market Value, By Type, 2018-2033 (US$ Million)

Table 27 Europe Nebulizer Market Value, By Portability, 2018-2033 (US$ Million)

Table 28 Europe Nebulizer Market Value, By Application, 2018-2033 (US$ Million)

Table 29 Europe Nebulizer Market Value, By End-User, 2018-2033 (US$ Million)

Table 30 Europe Nebulizer Market Value, By Country, 2018-2033 (US$ Million)

Table 31 South America Nebulizer Market Value, By Type, 2018-2033 (US$ Million)

Table 32 South America Nebulizer Market Value, By Portability, 2018-2033 (US$ Million)

Table 33 South America Nebulizer Market Value, By Application, 2018-2033 (US$ Million)

Table 34 South America Nebulizer Market Value, By End-User, 2018-2033 (US$ Million)

Table 35 South America Nebulizer Market Value, By Country, 2018-2033 (US$ Million)

Table 36 Middle East and Africa Nebulizer Market Value, By Type, 2018-2033 (US$ Million)

Table 37 Middle East and Africa Nebulizer Market Value, By Portability, 2018-2033 (US$ Million)

Table 38 Middle East and Africa Nebulizer Market Value, By Application, 2018-2033 (US$ Million)

Table 39 Middle East and Africa Nebulizer Market Value, By End-User, 2018-2033 (US$ Million)

Table 40 Middle East and Africa Nebulizer Market Value, By Country, 2018-2033 (US$ Million)

Table 41 OMRON Healthcare: Overview

Table 42 OMRON Healthcare: Product Portfolio

Table 43 OMRON Healthcare: Key Developments

Table 44 GE Healthcare: Overview

Table 45 GE Healthcare: Product Portfolio

Table 46 GE Healthcare: Key Developments

Table 47 Koninklijke Philips N.V.: Overview

Table 48 Koninklijke Philips N.V.: Product Portfolio

Table 49 Koninklijke Philips N.V.: Key Developments

Table 50 Allied Medical LLC: Overview

Table 51 Allied Medical LLC: Product Portfolio

Table 52 Allied Medical LLC: Key Developments

Table 53 Vectura Group Ltd: Overview

Table 54 Vectura Group Ltd: Product Portfolio

Table 55 Vectura Group Ltd: Key Developments

Table 56 PARI Respiratory Equipment, Inc.: Overview

Table 57 PARI Respiratory Equipment, Inc.: Product Portfolio

Table 58 PARI Respiratory Equipment, Inc.: Key Developments

Table 59 Aerogen: Overview

Table 60 Aerogen: Product Portfolio

Table 61 Aerogen: Key Developments

Table 62 Drive Devilbiss International: Overview

Table 63 Drive Devilbiss International: Product Portfolio

Table 64 Drive Devilbiss International: Key Developments

Table 65 Briggs Healthcare: Overview

Table 66 Briggs Healthcare: Product Portfolio

Table 67 Briggs Healthcare: Key Developments

Table 68 Beurer GmBH: Overview

Table 69 Beurer GmBH: Product Portfolio

Table 70 Beurer GmBH: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Nebulizer Market Value, 2018-2033 (US$ Million)

Figure 2 Global Nebulizer Market Share, By Type, 2024 & 2033 (%)

Figure 3 Global Nebulizer Market Share, By Portability, 2024 & 2033 (%)

Figure 4 Global Nebulizer Market Share, By Application, 2024 & 2033 (%)

Figure 5 Global Nebulizer Market Share, By End-User, 2024 & 2033 (%)

Figure 6 Global Nebulizer Market Share, By Region, 2024 & 2033 (%)

Figure 7 Global Nebulizer Market Y-o-Y Growth, By Type, 2024-2033 (%)

Figure 8 Jet Nebulizer Market Value, 2018-2033 (US$ Million)

Figure 9 Ultrasonic Nebulizer Market Value, 2018-2033 (US$ Million)

Figure 10 Mesh Nebulizer Market Value, 2018-2033 (US$ Million)

Figure 11 Global Nebulizer Market Y-o-Y Growth, By Portability, 2024-2033 (%)

Figure 12 Tabletop Nebulizer Portability in Global Nebulizer Market Value, 2018-2033 (US$ Million)

Figure 13 Portable Nebulizer Portability in Global Nebulizer Market Value, 2018-2033 (US$ Million)

Figure 14 Global Nebulizer Market Y-o-Y Growth, By Application, 2024-2033 (%)

Figure 15 COPD Application in Global Nebulizer Market Value, 2018-2033 (US$ Million)

Figure 16 Asthma Application in Global Nebulizer Market Value, 2018-2033 (US$ Million)

Figure 17 Others Application in Global Nebulizer Market Value, 2018-2033 (US$ Million)

Figure 18 Global Nebulizer Market Y-o-Y Growth, By End-User, 2024-2033 (%)

Figure 19 Hospitals End-User in Global Nebulizer Market Value, 2018-2033 (US$ Million)

Figure 20 Ambulatory Service Centres End-User in Global Nebulizer Market Value, 2018-2033 (US$ Million)

Figure 21 Homecare End-User in Global Nebulizer Market Value, 2018-2033 (US$ Million)

Figure 22 Global Nebulizer Market Y-o-Y Growth, By Region, 2024-2033 (%)

Figure 23 North America Nebulizer Market Value, 2018-2033 (US$ Million)

Figure 24 North America Nebulizer Market Share, By Type, 2024 & 2033 (%)

Figure 25 North America Nebulizer Market Share, By Portability, 2024 & 2033 (%)

Figure 26 North America Nebulizer Market Share, By Application, 2024 & 2033 (%)

Figure 27 North America Nebulizer Market Share, By End-User, 2024 & 2033 (%)

Figure 28 North America Nebulizer Market Share, By Country, 2024 & 2033 (%)

Figure 29 Asia-Pacific Nebulizer Market Value, 2018-2033 (US$ Million)

Figure 30 Asia-Pacific Nebulizer Market Share, By Type, 2024 & 2033 (%)

Figure 31 Asia-Pacific Nebulizer Market Share, By Portability, 2024 & 2033 (%)

Figure 32 Asia-Pacific Nebulizer Market Share, By Application, 2024 & 2033 (%)

Figure 33 Asia-Pacific Nebulizer Market Share, By End-User, 2024 & 2033 (%)

Figure 34 Asia-Pacific Nebulizer Market Share, By Country, 2024 & 2033 (%)

Figure 35 Europe Nebulizer Market Value, 2018-2033 (US$ Million)

Figure 36 Europe Nebulizer Market Share, By Type, 2024 & 2033 (%)

Figure 37 Europe Nebulizer Market Share, By Portability, 2024 & 2033 (%)

Figure 38 Europe Nebulizer Market Share, By Application, 2024 & 2033 (%)

Figure 39 Europe Nebulizer Market Share, By End-User, 2024 & 2033 (%)

Figure 40 Europe Nebulizer Market Share, By Country, 2024 & 2033 (%)

Figure 41 South America Nebulizer Market Value, 2018-2033 (US$ Million)

Figure 42 South America Nebulizer Market Share, By Type, 2024 & 2033 (%)

Figure 43 South America Nebulizer Market Share, By Portability, 2024 & 2033 (%)

Figure 44 South America Nebulizer Market Share, By Application, 2024 & 2033 (%)

Figure 45 South America Nebulizer Market Share, By End-User, 2024 & 2033 (%)

Figure 46 South America Nebulizer Market Share, By Country, 2024 & 2033 (%)

Figure 47 Middle East and Africa Nebulizer Market Value, 2018-2033 (US$ Million)

Figure 48 Middle East and Africa Nebulizer Market Share, By Type, 2024 & 2033 (%)

Figure 49 Middle East and Africa Nebulizer Market Share, By Portability, 2024 & 2033 (%)

Figure 50 Middle East and Africa Nebulizer Market Share, By Application, 2024 & 2033 (%)

Figure 51 Middle East and Africa Nebulizer Market Share, By End-User, 2024 & 2033 (%)

Figure 52 OMRON Healthcare: Financials

Figure 53 GE Healthcare: Financials

Figure 54 Koninklijke Philips N.V.: Financials

Figure 55 Allied Medical LLC: Financials

Figure 56 Vectura Group Ltd: Financials

Figure 57 PARI Respiratory Equipment, Inc.: Financials

Figure 58 Aerogen: Financials

Figure 59 Drive Devilbiss International: Financials

Figure 60 Briggs Healthcare: Financials

Figure 61 Beurer GmBH: Financials

글로벌 네뷸라이저 시장 – 2023-2030

Global Nebulizers Market - 2023-2030